Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0001599298-22-000102

Chief Financial Officer bought 36,215 shares at $0.97 ($35,129)

From the SEC's structured data for this filing

Trades in this filing

Dhingra Ankur · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-08-16 Purchase : show line 1 in the form +11,557 $0.97 $11,210 38,057 D
2022-08-16 Purchase : show line 2 in the form +24,658 $0.97 $23,918 38,196 I
Open-market purchases · 36,215 sh · avg $0.97 · $35,129
Loading xslF345X03/wf-form4_166076931714249.xml…